154 related articles for article (PubMed ID: 15755569)
1. Site-specific peptide vaccines for immunotherapy and immunization against chronic diseases, cancer, infectious diseases, and for veterinary applications.
Wang CY; Walfield AM
Vaccine; 2005 Mar; 23(17-18):2049-56. PubMed ID: 15755569
[TBL] [Abstract][Full Text] [Related]
2. Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy.
Finstad CL; Wang CY; Kowalski J; Zhang M; Li ML; Li XM; Xia WG; Bosland MC; Murthy KK; Walfield AM; Koff WC; Zamb TJ
Vaccine; 2004 Mar; 22(9-10):1300-13. PubMed ID: 15003660
[TBL] [Abstract][Full Text] [Related]
3. Bacterial lipopeptides constitute efficient novel immunogens and adjuvants in parenteral and oral immunization.
Bessler WG; Baier W; vd Esche U; Hoffmann P; Heinevetter L; Wiesmüller KH; Jung G
Behring Inst Mitt; 1997 Feb; (98):390-9. PubMed ID: 9382763
[TBL] [Abstract][Full Text] [Related]
4. Rational design of peptide vaccines for autoimmune disease: harnessing molecular recognition to fix a broken network.
Weathington NM; Blalock JE
Expert Rev Vaccines; 2003 Feb; 2(1):61-73. PubMed ID: 12901598
[TBL] [Abstract][Full Text] [Related]
5. Peptides as tools and drugs for immunotherapies.
Beck A; Klinguer-Hamour C; Bussat MC; Champion T; Haeuw JF; Goetsch L; Wurch T; Sugawara M; Milon A; Van Dorsselaer A; Nguyen T; Corvaïa N
J Pept Sci; 2007 Sep; 13(9):588-602. PubMed ID: 17602441
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the immune response against mixotope peptide libraries from a main antigenic site of foot-and-mouth disease virus.
Oliveira Ed; Jiménez-Clavero MA; Núñez JI; Sobrino F; Andreu D
Vaccine; 2005 Apr; 23(20):2647-57. PubMed ID: 15780448
[TBL] [Abstract][Full Text] [Related]
7. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.
Chackerian B; Rangel M; Hunter Z; Peabody DS
Vaccine; 2006 Sep; 24(37-39):6321-31. PubMed ID: 16806604
[TBL] [Abstract][Full Text] [Related]
8. A modified epitope identified for generation and monitoring of PSA-specific T cells in patients on early phases of PSA-based immunotherapeutic protocols.
Lundberg K; Roos AK; Pavlenko M; Leder C; Wehrum D; Guevara-Patiño J; Andersen RS; Pisa P
Vaccine; 2009 Mar; 27(10):1557-65. PubMed ID: 19171173
[TBL] [Abstract][Full Text] [Related]
9. Novel IgE peptide-based vaccine prevents the increase of IgE and down-regulates elevated IgE in rodents.
Peng Z; Liu Q; Wang Q; Rector E; Ma Y; Warrington R
Clin Exp Allergy; 2007 Jul; 37(7):1040-8. PubMed ID: 17581197
[TBL] [Abstract][Full Text] [Related]
10. The immunogenicity of recombinant and dimeric gonadotrophin-releasing hormone vaccines incorporating a T-helper epitope and GnRH or repeated GnRH units.
Jinshu X; Jingjing L; Duan P; Zheng Z; Ding M; Jie W; Rongyue C; Zhuoyi H
J Immunol Methods; 2004 Jun; 289(1-2):111-22. PubMed ID: 15251417
[TBL] [Abstract][Full Text] [Related]
11. The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope.
Benferhat R; Martinon F; Krust B; Le Grand R; Hovanessian AG
Mol Immunol; 2009 Feb; 46(4):705-12. PubMed ID: 19010547
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel foot-and-mouth disease virus specific T-cell epitopes in c/c and d/d haplotype miniature swine.
Gerner W; Denyer MS; Takamatsu HH; Wileman TE; Wiesmüller KH; Pfaff E; Saalmüller A
Virus Res; 2006 Nov; 121(2):223-8. PubMed ID: 16934904
[TBL] [Abstract][Full Text] [Related]
13. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
[TBL] [Abstract][Full Text] [Related]
14. Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein.
Olive C; Sun HK; Ho MF; Dyer J; Horváth A; Toth I; Good MF
J Infect Dis; 2006 Aug; 194(3):316-24. PubMed ID: 16826479
[TBL] [Abstract][Full Text] [Related]
15. [Tumor antigens presented to T helper lymphocytes--critical components of the cancer vaccine].
Bartnes K
Tidsskr Nor Laegeforen; 2001 Oct; 121(25):2941-5. PubMed ID: 11715777
[TBL] [Abstract][Full Text] [Related]
16. Recognition of prostate and melanoma tumor cells by six-transmembrane epithelial antigen of prostate-specific helper T lymphocytes in a human leukocyte antigen class II-restricted manner.
Kobayashi H; Nagato T; Sato K; Aoki N; Kimura S; Murakami M; Iizuka H; Azumi M; Kakizaki H; Tateno M; Celis E
Cancer Res; 2007 Jun; 67(11):5498-504. PubMed ID: 17545632
[TBL] [Abstract][Full Text] [Related]
17. Towards a multi-site synthetic vaccine to foot-and-mouth disease: addition of discontinuous site peptide mimic increases the neutralization response in immunized animals.
Villén J; de Oliveira E; Núñez JI; Molina N; Sobrino F; Andreu D
Vaccine; 2004 Sep; 22(27-28):3523-9. PubMed ID: 15315831
[TBL] [Abstract][Full Text] [Related]
18. Specific antitumor immune response induced by a novel DNA vaccine composed of multiple CTL and T helper cell epitopes of prostate cancer associated antigens.
Qin H; Zhou C; Wang D; Ma W; Liang X; Lin C; Zhang Y; Zhang S
Immunol Lett; 2005 Jun; 99(1):85-93. PubMed ID: 15894116
[TBL] [Abstract][Full Text] [Related]
19. A peptide of foot-and-mouth disease virus serotype Asia1 generating a neutralizing antibody response, and an immunostimulatory peptide.
Wang JL; Liu MQ; Han J; Chen WZ; Cong W; Cheng G; Gao YH; Lu YG; Chen JL; Zuo XP; Yan WY; Zheng ZX
Vet Microbiol; 2007 Dec; 125(3-4):224-31. PubMed ID: 17656048
[TBL] [Abstract][Full Text] [Related]
20. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
